Gene Switch Market Report and Forecast 2025-2034
Description
The global gene switch market was valued at USD 670.00 Million in 2024 driven by advancements in gene therapy across the globe. It is expected to grow at a CAGR of 11.50% during the forecast period of 2025-2034 and attain a market value of USD 1989.86 Million by 2034.
Gene Switch Market Overview
Gene switch is used to regulate gene expression that can be crucial for therapeutic development and research applications for managing various diseases. Rising investments in genetic research and biopharmaceutical advancements are primary growth drivers. Trends such as precision gene editing and synthetic biology are unlocking new market opportunities, aligning with the growing demand for innovative therapies and propelling market expansion during the forecast period.
Gene Switch Market Growth Drivers
Rising Investments in Genetic Research Drives Market Growth
Government and private funding in genetic research are accelerating the development of gene switch technologies. These investments are driving advancements in therapies for genetic disorders and optimizing biopharmaceutical processes, directly contributing to the growth of the market. Rising fundings are expected to increase adoption and expand applications, ensuring steady market progression during the forecast period.
Gene Switch Market Trends
Several trends and developments are being observed in the market to enhance the current situation. Some of the trends are as follows:
Rising Demand for Precision Gene Editing to Drive Market Expansion
The adoption of precision gene editing technologies, such as CRISPR-Cas systems, is enhancing the role of gene switches in therapeutic and research applications. These advancements enable accurate regulation of gene expression, addressing complex medical needs. This trend is expected to significantly expand the market by supporting the development of innovative disease therapies during the forecast period.
Adoption of Synthetic Biology Tools to Boost Gene Switch Market Growth
Synthetic biology tools are revolutionizing gene circuit design, improving the efficiency and adaptability of gene switches. These innovations are accelerating their application in drug discovery and biopharmaceutical production. As these tools continue to streamline processes and deliver cost-effective solutions, they are projected to drive substantial market growth across various industries.
Advancements in Gene Therapy Set to Transform Gene Switch Market Landscape
Progress in gene therapy is increasing the demand for gene switches to precisely control therapeutic gene expression. Their integration into advanced treatments for genetic disorders highlights their critical role in precision medicine. With rising adoption of gene therapy globally, gene switches are set to become indispensable, contributing to significant growth in the healthcare-focused market.
Increasing Utilization in Agricultural Biotechnology to Expand Gene Switches Market Size
The use of gene switches in agricultural biotechnology is gaining traction, enabling higher crop yields, better stress resistance, and the incorporation of desirable traits. These applications align with the growing need for sustainable agriculture and food security. As precision farming becomes a priority, the demand for gene switches in this sector is anticipated to drive market expansion during the forecast period.
Gene Switch Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
Market Segmentation Based on Application Set to Witness Substantial Growth
The market breakup by application includes gene therapy, synthetic biology, drug discovery and development, research and academic use. Among these, gene therapy is expected to lead the market share due to its success in treating cancers and rare diseases with precision. Growing clinical trial activity and regulatory approvals are driving its adoption, while advancements in personalized treatments will continue to propel this segment's expansion during the forecast period.
Gene Switch Market Analysis by Region
Based on region, the market report covers North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Among these, North America is expected to dominate the market due to its robust healthcare infrastructure and a strong presence of prominent pharmaceutical companies. Additionally, the increasing adoption of advanced treatments and supportive regulatory frameworks are further boosting market growth in this region.
Leading Players in the Gene Switch Market
The key features of the market report include patent analysis, clinical trials analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies are:
aceRNA Technologies Co., Ltd.
Established in 2018 in Japan, aceRNA Technologies consists of RNA-based gene switches for precise control of gene expression. Its stellar portfolio includes the mRNA Switch System that promotes controlled development in therapeutic applications, particularly in cancer immunotherapy and regenerative medicine.
Autolus Therapeutics Plc.
Founded in 2014, and based in London, United Kingdom, Autolus develops T-cell programming and gene control technologies. Its development candidates include AUTO6NG, a CAR T-cell therapy with gene switch-integrated targeting of solid tumors to offer precision and safety in next-gen cell therapies.
Bellicum Pharmaceuticals
Founded in 2004 and based in Texas, United States, Bellicum Pharmaceuticals develops controllable cell therapies. Its product GoCAR-T highlights an embedded gene switch permitting tunable T-cell activity, providing advanced safety and efficacy in oncology treatments.
Cellectis SA
Established in 1999 and headquartered in Paris, France; its product portfolio includes the TALEN-based Gene Switch System, allowing precise control of gene expression for cancer immunotherapies and paving the way for the development of targeted customizable therapeutic solutions.
Other companies include Kiromic BioPharma Inc., panCELLa Inc., Precigen Inc., Sana Biotechnology Inc., and Sangamo Therapeutics, Inc., among others.
Key Questions Answered in the Global Gene Switch Market
Gene Switch Market Overview
Gene switch is used to regulate gene expression that can be crucial for therapeutic development and research applications for managing various diseases. Rising investments in genetic research and biopharmaceutical advancements are primary growth drivers. Trends such as precision gene editing and synthetic biology are unlocking new market opportunities, aligning with the growing demand for innovative therapies and propelling market expansion during the forecast period.
Gene Switch Market Growth Drivers
Rising Investments in Genetic Research Drives Market Growth
Government and private funding in genetic research are accelerating the development of gene switch technologies. These investments are driving advancements in therapies for genetic disorders and optimizing biopharmaceutical processes, directly contributing to the growth of the market. Rising fundings are expected to increase adoption and expand applications, ensuring steady market progression during the forecast period.
Gene Switch Market Trends
Several trends and developments are being observed in the market to enhance the current situation. Some of the trends are as follows:
Rising Demand for Precision Gene Editing to Drive Market Expansion
The adoption of precision gene editing technologies, such as CRISPR-Cas systems, is enhancing the role of gene switches in therapeutic and research applications. These advancements enable accurate regulation of gene expression, addressing complex medical needs. This trend is expected to significantly expand the market by supporting the development of innovative disease therapies during the forecast period.
Adoption of Synthetic Biology Tools to Boost Gene Switch Market Growth
Synthetic biology tools are revolutionizing gene circuit design, improving the efficiency and adaptability of gene switches. These innovations are accelerating their application in drug discovery and biopharmaceutical production. As these tools continue to streamline processes and deliver cost-effective solutions, they are projected to drive substantial market growth across various industries.
Advancements in Gene Therapy Set to Transform Gene Switch Market Landscape
Progress in gene therapy is increasing the demand for gene switches to precisely control therapeutic gene expression. Their integration into advanced treatments for genetic disorders highlights their critical role in precision medicine. With rising adoption of gene therapy globally, gene switches are set to become indispensable, contributing to significant growth in the healthcare-focused market.
Increasing Utilization in Agricultural Biotechnology to Expand Gene Switches Market Size
The use of gene switches in agricultural biotechnology is gaining traction, enabling higher crop yields, better stress resistance, and the incorporation of desirable traits. These applications align with the growing need for sustainable agriculture and food security. As precision farming becomes a priority, the demand for gene switches in this sector is anticipated to drive market expansion during the forecast period.
Gene Switch Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
- Inducible Gene Switches
- Repressible Gene Switches
- Gene Therapy
- Synthetic Biology
- Drug Discovery and Development
- Research and Academic Use
- CRISPR-based Systems
- Zinc Finger Proteins (ZFP)
- Transcription Activator-Like Effectors (TALEs)
- RNA Interference (RNAi)
- Epigenetic Modulators
- Viral Vectors
- Non-viral Vectors
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutions
- Contract Research Organizations (CROs)
Market Segmentation Based on Application Set to Witness Substantial Growth
The market breakup by application includes gene therapy, synthetic biology, drug discovery and development, research and academic use. Among these, gene therapy is expected to lead the market share due to its success in treating cancers and rare diseases with precision. Growing clinical trial activity and regulatory approvals are driving its adoption, while advancements in personalized treatments will continue to propel this segment's expansion during the forecast period.
Gene Switch Market Analysis by Region
Based on region, the market report covers North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Among these, North America is expected to dominate the market due to its robust healthcare infrastructure and a strong presence of prominent pharmaceutical companies. Additionally, the increasing adoption of advanced treatments and supportive regulatory frameworks are further boosting market growth in this region.
Leading Players in the Gene Switch Market
The key features of the market report include patent analysis, clinical trials analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies are:
aceRNA Technologies Co., Ltd.
Established in 2018 in Japan, aceRNA Technologies consists of RNA-based gene switches for precise control of gene expression. Its stellar portfolio includes the mRNA Switch System that promotes controlled development in therapeutic applications, particularly in cancer immunotherapy and regenerative medicine.
Autolus Therapeutics Plc.
Founded in 2014, and based in London, United Kingdom, Autolus develops T-cell programming and gene control technologies. Its development candidates include AUTO6NG, a CAR T-cell therapy with gene switch-integrated targeting of solid tumors to offer precision and safety in next-gen cell therapies.
Bellicum Pharmaceuticals
Founded in 2004 and based in Texas, United States, Bellicum Pharmaceuticals develops controllable cell therapies. Its product GoCAR-T highlights an embedded gene switch permitting tunable T-cell activity, providing advanced safety and efficacy in oncology treatments.
Cellectis SA
Established in 1999 and headquartered in Paris, France; its product portfolio includes the TALEN-based Gene Switch System, allowing precise control of gene expression for cancer immunotherapies and paving the way for the development of targeted customizable therapeutic solutions.
Other companies include Kiromic BioPharma Inc., panCELLa Inc., Precigen Inc., Sana Biotechnology Inc., and Sangamo Therapeutics, Inc., among others.
Key Questions Answered in the Global Gene Switch Market
- What was the global gene switch market value in 2024?
- What is the global gene switch market forecast outlook for 2025-2034?
- What are the regional markets covered in the EMR report?
- What is the market segmentation based on the product?
- What is the market breakup based on the type of application?
- What is the market breakup based on the type of technology?
- What is the market breakup based on the type of delivery method?
- What is the market breakup based on the type of end user?
- What are the major factors aiding the gene switch market demand?
- What are the market's major drivers, opportunities, and restraints?
- Which regional market is expected to lead the market share in the forecast period?
- Which country is expected to experience expedited growth during the forecast period?
- What are the major gene switch market trends?
- How does the rise in the geriatric population impact the market size?
- Who are the key players involved in the gene switch market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Table of Contents
400 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Gene Switch Market Overview
- 3.1 Global Gene Switch Market Historical Value (2018-2024)
- 3.2 Global Gene Switch Market Forecast Value (2025-2034)
- 4 Vendor Positioning Analysis
- 4.1 Key Vendors
- 4.2 Prospective Leaders
- 4.3 Niche Leaders
- 4.4 Disruptors
- 5 Global Gene Switch Market Landscape*
- 5.1 Global Gene Switch Market: Developers Landscape
- 5.1.1 Analysis by Year of Establishment
- 5.1.2 Analysis by Company Size
- 5.1.3 Analysis by Region
- 5.2 Global Gene Switch Market: Product Landscape
- 5.2.1 Analysis by Product
- 5.2.2 Analysis by Application
- 5.2.3 Analysis by Technology
- 5.2.4 Analysis by Delivery Method
- 6 Global Gene Switch Market Dynamics
- 6.1 Market Drivers and Constraints
- 6.2 SWOT Analysis
- 6.2.1 Strengths
- 6.2.2 Weaknesses
- 6.2.3 Opportunities
- 6.2.4 Threats
- 6.3 PESTEL Analysis
- 6.3.1 Political
- 6.3.2 Economic
- 6.3.3 Social
- 6.3.4 Technological
- 6.3.5 Legal
- 6.3.6 Environment
- 6.4 Porter’s Five Forces Model
- 6.4.1 Bargaining Power of Suppliers
- 6.4.2 Bargaining Power of Buyers
- 6.4.3 Threat of New Entrants
- 6.4.4 Threat of Substitutes
- 6.4.5 Degree of Rivalry
- 6.5 Key Demand Indicators
- 6.6 Key Price Indicators
- 6.7 Industry Events, Initiatives, and Trends
- 6.8 Value Chain Analysis
- 7 Global Gene Switch Market Segmentation (218-2034)
- 7.1 Global Gene Switch Market (2018-2034) by Product
- 7.1.1 Market Overview
- 7.1.2 Inducible Gene Switches
- 7.1.3 Repressible Gene Switches
- 7.2 Global Gene Switch Market (2018-2034) by Application
- 7.2.1 Market Overview
- 7.2.2 Gene Therapy
- 7.2.3 Synthetic Biology
- 7.2.4 Drug Discovery and Development
- 7.2.5 Research and Academic Use
- 7.3 Global Gene Switch Market (2018-2034) by Technology
- 7.3.1 Market Overview
- 7.3.2 CRISPR-based Systems
- 7.3.3 Zinc Finger Proteins (ZFP)
- 7.3.4 Transcription Activator-Like Effectors (TALEs)
- 7.3.5 RNA Interference (RNAi)
- 7.3.6 Epigenetic Modulators
- 7.4 Global Gene Switch Market (2018-2034) by Delivery Method
- 7.4.1 Market Overview
- 7.4.2 Viral Vectors
- 7.4.3 Non-viral Vectors
- 7.5 Global Gene Switch Market (2018-2034) by End User
- 7.5.1 Market Overview
- 7.5.2 Pharmaceutical and Biotechnology Companies
- 7.5.3 Academic and Research Institutions
- 7.5.4 Contract Research Organizations (CROs)
- 7.6 Global Gene Switch Market (2018-2034) by Region
- 7.6.1 Market Overview
- 7.6.2 North America
- 7.6.3 Europe
- 7.6.4 Asia Pacific
- 7.6.5 Latin America
- 7.6.6 Middle East and Africa
- 8 North America Gene Switch Market (218-2034)
- 8.1 North America Gene Switch Market (2018-2034) by Product
- 8.1.1 Market Overview
- 8.1.2 Inducible Gene Switches
- 8.1.3 Repressible Gene Switches
- 8.2 North America Gene Switch Market (2018-2034) by Application
- 8.2.1 Market Overview
- 8.2.2 Gene Therapy
- 8.2.3 Synthetic Biology
- 8.2.4 Drug Discovery and Development
- 8.2.5 Research and Academic Use
- 8.3 North America Gene Switch Market (2018-2034) by Technology
- 8.3.1 Market Overview
- 8.3.2 CRISPR-based Systems
- 8.3.3 Zinc Finger Proteins (ZFP)
- 8.3.4 Transcription Activator-Like Effectors (TALEs)
- 8.3.5 RNA Interference (RNAi)
- 8.3.6 Epigenetic Modulators
- 8.4 North America Gene Switch Market (2018-2034) by Delivery Method
- 8.4.1 Market Overview
- 8.4.2 Viral Vectors
- 8.4.3 Non-viral Vectors
- 8.5 North America Gene Switch Market (2018-2034) by End User
- 8.5.1 Market Overview
- 8.5.2 Pharmaceutical and Biotechnology Companies
- 8.5.3 Academic and Research Institutions
- 8.5.4 Contract Research Organizations (CROs)
- 8.6 North America Gene Switch Market (2018-2034) by Country
- 8.6.1 United States of America
- 8.6.1.1 United States of America Gene Switch Market (2018-2034) by Product
- 8.6.2 Canada
- 8.6.2.1 Canada Gene Switch Market (2018-2034) by Product
- 9 Europe Gene Switch Market (218-2034)
- 9.1 Europe Gene Switch Market (2018-2034) by Product
- 9.1.1 Market Overview
- 9.1.2 Inducible Gene Switches
- 9.1.3 Repressible Gene Switches
- 9.2 Europe Gene Switch Market (2018-2034) by Application
- 9.2.1 Market Overview
- 9.2.2 Gene Therapy
- 9.2.3 Synthetic Biology
- 9.2.4 Drug Discovery and Development
- 9.2.5 Research and Academic Use
- 9.3 Europe Gene Switch Market (2018-2034) by Technology
- 9.3.1 Market Overview
- 9.3.2 CRISPR-based Systems
- 9.3.3 Zinc Finger Proteins (ZFP)
- 9.3.4 Transcription Activator-Like Effectors (TALEs)
- 9.3.5 RNA Interference (RNAi)
- 9.3.6 Epigenetic Modulators
- 9.4 Europe Gene Switch Market (2018-2034) by Delivery Method
- 9.4.1 Market Overview
- 9.4.2 Viral Vectors
- 9.4.3 Non-viral Vectors
- 9.5 Europe Gene Switch Market (2018-2034) by End User
- 9.5.1 Market Overview
- 9.5.2 Pharmaceutical and Biotechnology Companies
- 9.5.3 Academic and Research Institutions
- 9.5.4 Contract Research Organizations (CROs)
- 9.6 Europe Gene Switch Market (2018-2034) by Country
- 9.6.1 United Kingdom
- 9.6.1.1 United Kingdom Gene Switch Market (2018-2034) by Product
- 9.6.2 Germany
- 9.6.2.1 Germany Gene Switch Market (2018-2034) by Product
- 9.6.3 France
- 9.6.3.1 France Gene Switch Market (2018-2034) by Product
- 9.6.4 Italy
- 9.6.4.1 Italy Gene Switch Market (2018-2034) by Product
- 9.6.5 Others
- 10 Asia Pacific Gene Switch Market (218-2034)
- 10.1 Asia Pacific Gene Switch Market (2018-2034) by Product
- 10.1.1 Market Overview
- 10.1.2 Inducible Gene Switches
- 10.1.3 Repressible Gene Switches
- 10.2 Asia Pacific Gene Switch Market (2018-2034) by Application
- 10.2.1 Market Overview
- 10.2.2 Gene Therapy
- 10.2.3 Synthetic Biology
- 10.2.4 Drug Discovery and Development
- 10.2.5 Research and Academic Use
- 10.3 Asia Pacific Gene Switch Market (2018-2034) by Technology
- 10.3.1 Market Overview
- 10.3.2 CRISPR-based Systems
- 10.3.3 Zinc Finger Proteins (ZFP)
- 10.3.4 Transcription Activator-Like Effectors (TALEs)
- 10.3.5 RNA Interference (RNAi)
- 10.3.6 Epigenetic Modulators
- 10.4 Asia Pacific Gene Switch Market (2018-2034) by Delivery Method
- 10.4.1 Market Overview
- 10.4.2 Viral Vectors
- 10.4.3 Non-viral Vectors
- 10.5 Asia Pacific Gene Switch Market (2018-2034) by End User
- 10.5.1 Market Overview
- 10.5.2 Pharmaceutical and Biotechnology Companies
- 10.5.3 Academic and Research Institutions
- 10.5.4 Contract Research Organizations (CROs)
- 10.6 Asia Pacific Gene Switch Market (2018-2034) by Country
- 10.6.1 China
- 10.6.1.1 China Gene Switch Market (2018-2034) by Product
- 10.6.2 Japan
- 10.6.2.1 Japan Gene Switch Market (2018-2034) by Product
- 10.6.3 India
- 10.6.3.1 India Gene Switch Market (2018-2034) by Product
- 10.6.4 ASEAN
- 10.6.4.1 ASEAN Gene Switch Market (2018-2034) by Product
- 10.6.5 Australia
- 10.6.5.1 Australia Gene Switch Market (2018-2034) by Product
- 10.6.6 Others
- 11 Latin America Gene Switch Market (218-2034)
- 11.1 Latin America Gene Switch Market (2018-2034) by Product
- 11.1.1 Market Overview
- 11.1.2 Inducible Gene Switches
- 11.1.3 Repressible Gene Switches
- 11.2 Latin America Gene Switch Market (2018-2034) By Application
- 11.2.1 Market Overview
- 11.2.2 Gene Therapy
- 11.2.3 Synthetic Biology
- 11.2.4 Drug Discovery and Development
- 11.2.5 Research and Academic Use
- 11.3 Latin America Gene Switch Market (2018-2034) by Technology
- 11.3.1 Market Overview
- 11.3.2 CRISPR-based Systems
- 11.3.3 Zinc Finger Proteins (ZFP)
- 11.3.4 Transcription Activator-Like Effectors (TALEs)
- 11.3.5 RNA Interference (RNAi)
- 11.3.6 Epigenetic Modulators
- 11.4 Latin America Gene Switch Market (2018-2034) by Delivery Method
- 11.4.1 Market Overview
- 11.4.2 Viral Vectors
- 11.4.3 Non-viral Vectors
- 11.5 Latin America Gene Switch Market (2018-2034) by End User
- 11.5.1 Market Overview
- 11.5.2 Pharmaceutical and Biotechnology Companies
- 11.5.3 Academic and Research Institutions
- 11.5.4 Contract Research Organizations (CROs)
- 11.6 Latin America Gene Switch Market (2018-2034) by Country
- 11.6.1 Brazil
- 11.6.1.1 Brazil Gene Switch Market (2018-2034) by Product
- 11.6.2 Argentina
- 11.6.2.1 Argentina Gene Switch Market (2018-2034) by Product
- 11.6.3 Mexico
- 11.6.3.1 Mexico Gene Switch Market (2018-2034) by Product
- 11.6.4 Others
- 12 Middle East and Africa Gene Switch Market (218-2034)
- 12.1 Middle East and Africa Gene Switch Market (2018-2034) by Product
- 12.1.1 Market Overview
- 12.1.2 Inducible Gene Switches
- 12.1.3 Repressible Gene Switches
- 12.2 Middle East and Africa Gene Switch Market (2018-2034) By Application
- 12.2.1 Market Overview
- 12.2.2 Gene Therapy
- 12.2.3 Synthetic Biology
- 12.2.4 Drug Discovery and Development
- 12.2.5 Research and Academic Use
- 12.3 Middle East and Africa Gene Switch Market (2018-2034) by Technology
- 12.3.1 Market Overview
- 12.3.2 CRISPR-based Systems
- 12.3.3 Zinc Finger Proteins (ZFP)
- 12.3.4 Transcription Activator-Like Effectors (TALEs)
- 12.3.5 RNA Interference (RNAi)
- 12.3.6 Epigenetic Modulators
- 12.4 Middle East and Africa Gene Switch Market (2018-2034) by Delivery Method
- 12.4.1 Market Overview
- 12.4.2 Viral Vectors
- 12.4.3 Non-viral Vectors
- 12.5 Middle East and Africa Gene Switch Market (2018-2034) by End User
- 12.5.1 Market Overview
- 12.5.2 Pharmaceutical and Biotechnology Companies
- 12.5.3 Academic and Research Institutions
- 12.5.4 Contract Research Organizations (CROs)
- 12.6 Middle East and Africa Gene Switch Market (2018-2034) by Country
- 12.6.1 Saudi Arabia
- 12.6.1.1 Saudi Arabia Gene Switch Market (2018-2034) by Product
- 12.6.2 United Arab Emirates
- 12.6.2.1 United Arab Emirates Gene Switch Market (2018-2034) by Product
- 12.6.3 Nigeria
- 12.6.3.1 Nigeria Gene Switch Market (2018-2034) by Product
- 12.6.4 South Africa
- 12.6.4.1 South Africa Gene Switch Market (2018-2034) by Product
- 12.6.5 Others
- 13 Regulatory Framework
- 13.1 Regulatory Overview
- 13.2 US FDA
- 13.3 EU EMA
- 13.4 Japan PMDA
- 13.5 India CDSCO
- 13.6 Others
- 14 Patent Analysis
- 14.1 Analysis by Type of Patent
- 14.2 Analysis by Publication Year
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Patent Age
- 14.5 Analysis by CPC Analysis
- 14.6 Analysis by Patent Valuation
- 15 Clinical Trials Analysis
- 15.1 Analysis by Trial Registration Year
- 15.2 Analysis by Trial Status
- 15.3 Analysis by Trial Phase
- 15.4 Analysis by Therapeutic Area
- 15.5 Analysis by Geography
- 16 Grants Analysis
- 16.1 Analysis by Year
- 16.2 Analysis by Amount Awarded
- 16.3 Analysis by Issuing Authority
- 16.4 Analysis by Grant Application
- 16.5 Analysis by Funding Institute
- 16.6 Analysis by NIH Departments
- 16.7 Analysis by Recipient Organization
- 17 Funding and Investment Analysis
- 17.1 Analysis by Funding Instances
- 17.2 Analysis by Drug Class of Funding
- 17.3 Analysis by Funding Amount
- 17.4 Analysis by Leading Players
- 17.5 Analysis by Leading Investors
- 17.6 Analysis by Geography
- 18 Strategic Initiatives
- 18.1 Analysis by Partnership Instances
- 18.2 Analysis by Drug Class of Partnership
- 18.3 Analysis by Leading Players
- 18.4 Analysis by Geography
- 19 Supplier Landscape
- 19.1 Market Share Analysis, by Region (Top 5 Companies)
- 19.1.1 Market Share Analysis: Global
- 19.1.2 Market Share Analysis: North America
- 19.1.3 Market Share Analysis: Europe
- 19.1.4 Market Share Analysis: Asia Pacific
- 19.1.5 Market Share Analysis: Others
- 19.2 aceRNA Technologies Co., Ltd.
- 19.2.1 Financial Analysis
- 19.2.2 Product Portfolio
- 19.2.3 Demographic Reach and Achievements
- 19.2.4 Company News and Development
- 19.2.5 Certifications
- 19.3 Autolus Therapeutics Plc.
- 19.3.1 Financial Analysis
- 19.3.2 Product Portfolio
- 19.3.3 Demographic Reach and Achievements
- 19.3.4 Company News and Development
- 19.3.5 Certifications
- 19.4 Bellicum Pharmaceuticals
- 19.4.1 Financial Analysis
- 19.4.2 Product Portfolio
- 19.4.3 Demographic Reach and Achievements
- 19.4.4 Company News and Development
- 19.4.5 Certifications
- 19.5 Cellectis SA
- 19.5.1 Financial Analysis
- 19.5.2 Product Portfolio
- 19.5.3 Demographic Reach and Achievements
- 19.5.4 Company News and Development
- 19.5.5 Certifications
- 19.6 Kiromic BioPharma Inc.
- 19.6.1 Financial Analysis
- 19.6.2 Product Portfolio
- 19.6.3 Demographic Reach and Achievements
- 19.6.4 Company News and Development
- 19.6.5 Certifications
- 19.7 panCELLa Inc.
- 19.7.1 Financial Analysis
- 19.7.2 Product Portfolio
- 19.7.3 Demographic Reach and Achievements
- 19.7.4 Company News and Development
- 19.7.5 Certifications
- 19.8 Precigen Inc.
- 19.8.1 Financial Analysis
- 19.8.2 Product Portfolio
- 19.8.3 Demographic Reach and Achievements
- 19.8.4 Company News and Development
- 19.8.5 Certifications
- 19.9 Sana Biotechnology Inc.
- 19.9.1 Financial Analysis
- 19.9.2 Product Portfolio
- 19.9.3 Demographic Reach and Achievements
- 19.9.4 Company News and Development
- 19.9.5 Certifications
- 19.10 Sangamo Therapeutics, Inc.
- 19.10.1 Financial Analysis
- 19.10.2 Product Portfolio
- 19.10.3 Demographic Reach and Achievements
- 19.10.4 Company News and Development
- 19.10.5 Certifications
- 20 Global Gene Switch Market – Distribution Model (Additional Insight)
- 20.1 Overview
- 20.2 Potential Distributors
- 20.3 Key Parameters for Distribution Partner Assessment
- 21 Key Opinion Leaders (KOL) Insights (Additional Insight)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
